skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Abstract of Title
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Total Assignments: 2
Patent #:
11752106
Issue Dt:
09/12/2023
Application #:
17475622
Filing Dt:
09/15/2021
Publication #:
20220241206
Pub Dt:
08/04/2022
Inventors:
Eleni DOKOU, John P. CAESAR JR., Laura DAS, Patricia Nell HURTER, Meghan M. JOHNSTON et al
Title:
PHARMACEUTICAL COMPOSITION AND ADMINISTRATIONS THEREOF
Assignment: 1
Reel/Frame:
060742/0497Recorded: 08/08/2022Pages: 18
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
DOKOU, ELENI
Exec Dt:
02/26/2013
JAMZAD, SHAHLA
Exec Dt:
02/26/2013
CAESAR, JOHN P., JR.
Exec Dt:
02/25/2013
DAS, LAURA
Exec Dt:
02/25/2013
FAWAZ, MAJED
Exec Dt:
02/27/2013
GU, CHONG-HUI
Exec Dt:
03/04/2013
HURTER, PATRICIA NELL
Exec Dt:
02/27/2013
ISRANI, MEGHNA JAI
Exec Dt:
02/25/2013
JOHNSTON, MEGHAN M.
Exec Dt:
02/25/2013
KNEZIC, DRAGUTIN
Exec Dt:
02/26/2013
KUZMISSION, ANDREW G.
Exec Dt:
02/26/2013
WANG, HONGREN
Exec Dt:
02/27/2013
Assignee:
VERTEX PHARMACEUTICALS INCORPORATED
130 WAVERLY STREET
CAMBRIDGE, MASSACHUSETTS 02139
Correspondent:
ERIC LEE
FINNEGAN
901 NEW YORK AVENUE NW
WASHINGTON, DC 20001
Assignment: 2
Reel/Frame:
061101/0942Recorded: 08/08/2022Pages: 2
Conveyance:
CHANGE OF ADDRESS
Assignor:
VERTEX PHARMACEUTICALS INCORPORATED
Exec Dt:
01/26/2016
Assignee:
VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON, MASSACHUSETTS 02210
Correspondent:
ERIC LEE
FINNEGAN
901 NEW YORK AVENUE NW
WASHINGTON, DC 20001

Search Results as of: 04/30/2024 12:37 AM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT